Form 4: Accolade Inc. Executive Robert Cavanaugh Reports Stock Transactions
SEC Form 4 Filing
Accolade Inc.'s President, Robert Cavanaugh, executed transactions involving the conversion of restricted stock units and the sale of shares to cover tax obligations.
Summary
- Robert Cavanaugh, President of Accolade Inc., reported transactions involving the company's stock.
- On November 11, 2024, 711 restricted stock units (RSUs) were converted into common stock.
- On November 12, 2024, 214 shares of common stock were sold at a price of $3.638 per share.
- The sale of shares was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary sale by Mr. Cavanaugh.
- Following these transactions, Mr. Cavanaugh directly owns 199,146 shares of Accolade Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, which is neither positive nor negative in itself.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- The vesting schedule of the RSUs, with a one-year cliff and subsequent monthly vesting, is a common structure for equity compensation.
- The 'sell to cover' mechanism for tax obligations is a typical practice to manage the tax implications of equity awards.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation activities.
- The sale of shares to cover tax obligations is a standard practice and does not indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| June 10, 2022 | The 'June 2022 RSU Vesting Commencement Date' for the restricted stock units. |
| November 11, 2024 | Date of conversion of 711 restricted stock units into common stock. |
| November 12, 2024 | Date of sale of 214 shares of common stock at $3.638 per share. |
| November 13, 2024 | Date of signature of the Form 4 filing. |
Keywords
Accolade Inc., Robert Cavanaugh, stock transactions, restricted stock units, Form 4, insider trading, tax withholding, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.